• OFID 2018:5 (Suppl 1) • Poster Abstracts rank sum). None of the azoles prolonged survival despite the significant reduction in the lung fungal burden (P < 0.002), possibly due to lack of reduction of fungal burden in kidneys and brains. MICA+ISAV did not enhance survival nor reduce tissue fungal burden vs. Background. C. difficile is the most common cause of hospital infections with a spectrum of presentation from asymptomatic carriage to severe recurrent diarrhea. Certain C. difficile ribotypes are associated with severe disease, but there are little data on ribotypes in asymptomatic carriers or severe recurrent disease. The aim of this study was to compare virulence potential of C.diff ribotypes with clinical disease severity.
Background. Lung infections with MDR-XDR-Pa in patients with CF are challenging due to the emergence of antibiotic resistance. We applied MBST with DDA to guide combination antibiotic therapy in an 18-year-old woman with CF. We investigated if this approach can assist in choosing effective regimens.
Methods. Consecutive Pa respiratory isolates were collected between 12/16 and 3/18 and typed with MLST. After automated antibiotic susceptibility (AST) and Kirby-Bauer testing, we performed double or triple DDAs. Combinations were based on mechanisms (MBST) of anti-pseudomonal antibiotics (e.g., targeting of penicillin-binding proteins, β-lactamase inhibition, and cell membrane disruption).
Results. During therapy, 1859 antibiotic-days were administered. Fifteen Pa isolates, (9 sequence type (ST) 2100 and 1 ST463) with varying AST patterns were found (figure). MBST with DDA revealed active combinations for isolates resistant to individual antibiotics (table) . These combinations led to a microbiological response permitting lung transplantation. Antibiotic regimens were also informed by allergies, clinical and radiologic findings.
Conclusion. Strains with evolving resistance profiles recapitulate the dynamic nature of respiratory infections in CF. Double or triple DDAs identified potential treatment options, e.g., vs. MDR-XDR Pa. MBST can support the management of challenging infections. 
